LUXEXPERIENCE BV (LUXE) Fundamental Analysis & Valuation

NYSE:LUXE • US55406W1036

Current stock price

7.83 USD
-0.3 (-3.69%)
At close:
7.83 USD
0 (0%)
After Hours:

This LUXE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

6

1. LUXE Profitability Analysis

1.1 Basic Checks

  • LUXE had negative earnings in the past year.
  • LUXE had a negative operating cash flow in the past year.
  • In the past 5 years LUXE reported 4 times negative net income.
  • The reported operating cash flow has been mixed in the past 5 years: LUXE reported negative operating cash flow in multiple years.
LUXE Yearly Net Income VS EBIT VS OCF VS FCFLUXE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 2025 0 200M 400M 600M

1.2 Ratios

  • LUXE's Return On Assets of 22.12% is amongst the best of the industry. LUXE outperforms 98.37% of its industry peers.
  • LUXE has a better Return On Equity (38.73%) than 90.24% of its industry peers.
  • LUXE has a Return On Invested Capital of 33.48%. This is amongst the best in the industry. LUXE outperforms 98.37% of its industry peers.
Industry RankSector Rank
ROA 22.12%
ROE 38.73%
ROIC 33.48%
ROA(3y)6.41%
ROA(5y)2.34%
ROE(3y)10.89%
ROE(5y)4.48%
ROIC(3y)N/A
ROIC(5y)N/A
LUXE Yearly ROA, ROE, ROICLUXE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 2025 0 10 20 30 40

1.3 Margins

  • Looking at the Profit Margin, with a value of 23.92%, LUXE belongs to the top of the industry, outperforming 99.19% of the companies in the same industry.
  • In the last couple of years the Profit Margin of LUXE has grown nicely.
  • The Operating Margin of LUXE (29.58%) is better than 99.19% of its industry peers.
  • In the last couple of years the Operating Margin of LUXE has grown nicely.
  • With a decent Gross Margin value of 47.51%, LUXE is doing good in the industry, outperforming 73.17% of the companies in the same industry.
  • In the last couple of years the Gross Margin of LUXE has remained more or less at the same level.
Industry RankSector Rank
OM 29.58%
PM (TTM) 23.92%
GM 47.51%
OM growth 3Y236.56%
OM growth 5Y61%
PM growth 3YN/A
PM growth 5Y99.64%
GM growth 3Y-2.22%
GM growth 5Y0.6%
LUXE Yearly Profit, Operating, Gross MarginsLUXE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 2025 0 10 20 30 40 50

5

2. LUXE Health Analysis

2.1 Basic Checks

  • LUXE has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
  • Compared to 1 year ago, LUXE has more shares outstanding
  • The number of shares outstanding for LUXE has been increased compared to 5 years ago.
  • Compared to 1 year ago, LUXE has a worse debt to assets ratio.
LUXE Yearly Shares OutstandingLUXE Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M
LUXE Yearly Total Debt VS Total AssetsLUXE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B

2.2 Solvency

  • An Altman-Z score of 3.70 indicates that LUXE is not in any danger for bankruptcy at the moment.
  • With an excellent Altman-Z score value of 3.70, LUXE belongs to the best of the industry, outperforming 82.93% of the companies in the same industry.
  • LUXE has a Debt/Equity ratio of 0.13. This is a healthy value indicating a solid balance between debt and equity.
  • LUXE has a Debt to Equity ratio of 0.13. This is in the better half of the industry: LUXE outperforms 67.48% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.13
Debt/FCF N/A
Altman-Z 3.7
ROIC/WACC4.74
WACC7.07%
LUXE Yearly LT Debt VS Equity VS FCFLUXE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 2025 0 500M 1B

2.3 Liquidity

  • LUXE has a Current Ratio of 2.12. This indicates that LUXE is financially healthy and has no problem in meeting its short term obligations.
  • With an excellent Current ratio value of 2.12, LUXE belongs to the best of the industry, outperforming 80.49% of the companies in the same industry.
  • A Quick Ratio of 0.83 indicates that LUXE may have some problems paying its short term obligations.
  • Looking at the Quick ratio, with a value of 0.83, LUXE is in the better half of the industry, outperforming 67.48% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.12
Quick Ratio 0.83
LUXE Yearly Current Assets VS Current LiabilitesLUXE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B

8

3. LUXE Growth Analysis

3.1 Past

  • The earnings per share for LUXE have decreased strongly by -286.80% in the last year.
  • LUXE shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 140.64% yearly.
  • Looking at the last year, LUXE shows a very strong growth in Revenue. The Revenue has grown by 133.67%.
  • LUXE shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 22.94% yearly.
EPS 1Y (TTM)-286.8%
EPS 3Y-53.29%
EPS 5Y140.64%
EPS Q2Q%-66.67%
Revenue 1Y (TTM)133.67%
Revenue growth 3Y22.31%
Revenue growth 5Y22.94%
Sales Q2Q%190.11%

3.2 Future

  • The Earnings Per Share is expected to grow by 94.95% on average over the next years. This is a very strong growth
  • LUXE is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 33.24% yearly.
EPS Next Y-1196.98%
EPS Next 2Y-53.18%
EPS Next 3Y94.95%
EPS Next 5YN/A
Revenue Next Year105.14%
Revenue Next 2Y47.13%
Revenue Next 3Y33.24%
Revenue Next 5YN/A

3.3 Evolution

  • The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
LUXE Yearly Revenue VS EstimatesLUXE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 500M 1B 1.5B 2B 2.5B
LUXE Yearly EPS VS EstimatesLUXE Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 0 0.2 -0.2 0.4 -0.4

2

4. LUXE Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for LUXE. In the last year negative earnings were reported.
  • Also next year LUXE is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
LUXE Price Earnings VS Forward Price EarningsLUXE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 -100 -200 -300

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of LUXE indicates a rather cheap valuation: LUXE is cheaper than 97.56% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 1.06
LUXE Per share dataLUXE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15

4.3 Compensation for Growth

  • LUXE has a very decent profitability rating, which may justify a higher PE ratio.
  • A more expensive valuation may be justified as LUXE's earnings are expected to grow with 94.95% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-53.18%
EPS Next 3Y94.95%

0

5. LUXE Dividend Analysis

5.1 Amount

  • LUXE does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

LUXE Fundamentals: All Metrics, Ratios and Statistics

LUXEXPERIENCE BV

NYSE:LUXE (3/27/2026, 8:04:00 PM)

After market: 7.83 0 (0%)

7.83

-0.3 (-3.69%)

Chartmill FA Rating
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)02-10
Earnings (Next)05-12
Inst Owners17.62%
Inst Owner Change-5.09%
Ins Owners2.39%
Ins Owner Change0%
Market Cap1.07B
Revenue(TTM)2.06B
Net Income(TTM)492.23M
Analysts76.36
Price Target11.12 (42.02%)
Short Float %21.65%
Short Ratio11.7
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)52.5%
Min EPS beat(2)-51.03%
Max EPS beat(2)156.02%
EPS beat(4)2
Avg EPS beat(4)263.99%
Min EPS beat(4)-51.03%
Max EPS beat(4)981.91%
EPS beat(8)4
Avg EPS beat(8)157.13%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-2.1%
Min Revenue beat(2)-2.67%
Max Revenue beat(2)-1.52%
Revenue beat(4)1
Avg Revenue beat(4)-0.87%
Min Revenue beat(4)-3.63%
Max Revenue beat(4)4.34%
Revenue beat(8)2
Avg Revenue beat(8)-1.44%
Revenue beat(12)4
Avg Revenue beat(12)-0.98%
Revenue beat(16)5
Avg Revenue beat(16)-1.66%
PT rev (1m)0%
PT rev (3m)7.92%
EPS NQ rev (1m)16.13%
EPS NQ rev (3m)-7.58%
EPS NY rev (1m)-22.58%
EPS NY rev (3m)-11.76%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-5.7%
Revenue NY rev (1m)0.43%
Revenue NY rev (3m)-1.62%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.45
P/FCF N/A
P/OCF N/A
P/B 0.73
P/tB 0.83
EV/EBITDA 1.06
EPS(TTM)-0.54
EYN/A
EPS(NY)-0.02
Fwd EYN/A
FCF(TTM)-0.3
FCFYN/A
OCF(TTM)-0.23
OCFYN/A
SpS17.38
BVpS10.73
TBVpS9.42
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA 22.12%
ROE 38.73%
ROCE 42.68%
ROIC 33.48%
ROICexc 47.26%
ROICexgc 55.82%
OM 29.58%
PM (TTM) 23.92%
GM 47.51%
FCFM N/A
ROA(3y)6.41%
ROA(5y)2.34%
ROE(3y)10.89%
ROE(5y)4.48%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3Y152.74%
ROICexgc growth 5Y37.03%
ROICexc growth 3Y191.83%
ROICexc growth 5Y55.11%
OM growth 3Y236.56%
OM growth 5Y61%
PM growth 3YN/A
PM growth 5Y99.64%
GM growth 3Y-2.22%
GM growth 5Y0.6%
F-Score4
Asset Turnover0.92
Health
Industry RankSector Rank
Debt/Equity 0.13
Debt/FCF N/A
Debt/EBITDA 0.25
Cap/Depr 19.94%
Cap/Sales 0.38%
Interest Coverage 63.04
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.12
Quick Ratio 0.83
Altman-Z 3.7
F-Score4
WACC7.07%
ROIC/WACC4.74
Cap/Depr(3y)96.22%
Cap/Depr(5y)91.08%
Cap/Sales(3y)1.56%
Cap/Sales(5y)1.38%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-286.8%
EPS 3Y-53.29%
EPS 5Y140.64%
EPS Q2Q%-66.67%
EPS Next Y-1196.98%
EPS Next 2Y-53.18%
EPS Next 3Y94.95%
EPS Next 5YN/A
Revenue 1Y (TTM)133.67%
Revenue growth 3Y22.31%
Revenue growth 5Y22.94%
Sales Q2Q%190.11%
Revenue Next Year105.14%
Revenue Next 2Y47.13%
Revenue Next 3Y33.24%
Revenue Next 5YN/A
EBIT growth 1Y5111.4%
EBIT growth 3Y311.67%
EBIT growth 5Y97.93%
EBIT Next Year107.45%
EBIT Next 3Y99.96%
EBIT Next 5YN/A
FCF growth 1Y11.49%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-9.91%
OCF growth 3YN/A
OCF growth 5YN/A

LUXEXPERIENCE BV / LUXE Fundamental Analysis FAQ

What is the fundamental rating for LUXE stock?

ChartMill assigns a fundamental rating of 5 / 10 to LUXE.


What is the valuation status for LUXE stock?

ChartMill assigns a valuation rating of 2 / 10 to LUXEXPERIENCE BV (LUXE). This can be considered as Overvalued.


What is the profitability of LUXE stock?

LUXEXPERIENCE BV (LUXE) has a profitability rating of 6 / 10.